Literature DB >> 17273819

Cyclic GMP in blood and minimal hepatic encephalopathy: fine-tuning of the diagnosis.

Jan Albrecht1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17273819     DOI： 10.1007/s00109-007-0160-y

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN： 0946-2716            Impact factor:   4.599


× No keyword cloud information.
  26 in total

1.  Critical flicker frequency for quantification of low-grade hepatic encephalopathy.

Authors:  Gerald Kircheis; Matthias Wettstein; Lars Timmermann; Alfons Schnitzler; Dieter Häussinger
Journal:  Hepatology       Date:  2002-02       Impact factor: 17.425

2.  Altered modulation of soluble guanylate cyclase in lymphocytes from patients with liver disease.

Authors:  Regina Corbalán; María-Dolores Miñana; Juan A Del Olmo; Miguel A Serra; José M Rodrigo; Vicente Felipo
Journal:  J Mol Med (Berl)       Date:  2001-10-27       Impact factor: 4.599

Review 3.  Driving under the influence of minimal hepatic encephalopathy.

Authors:  Juan Córdoba; Roy Lucke
Journal:  Hepatology       Date:  2004-03       Impact factor: 17.425

4.  Minimal hepatic encephalopathy: longitudinal effects of liver transplantation.

Authors:  Katia Mattarozzi; Andrea Stracciari; Luca Vignatelli; Roberto D'Alessandro; Maria Cristina Morelli; Maria Guarino
Journal:  Arch Neurol       Date:  2004-02

Review 5.  Characteristics of minimal hepatic encephalopathy.

Authors:  Piero Amodio; Sara Montagnese; Angelo Gatta; Marsha Y Morgan
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

6.  Chronic hyperammonemia in vivo impairs long-term potentiation in hippocampus by altering activation of cyclic GMP-dependent-protein kinase and of phosphodiesterase 5.

Authors:  Pilar Monfort; María-Dolores Muñoz; Vicente Felipo
Journal:  J Neurochem       Date:  2005-08       Impact factor: 5.372

7.  Oral administration of sildenafil restores learning ability in rats with hyperammonemia and with portacaval shunts.

Authors:  Slaven Erceg; Pilar Monfort; Mariluz Hernández-Viadel; Regina Rodrigo; Carmina Montoliu; Vicente Felipo
Journal:  Hepatology       Date:  2005-02       Impact factor: 17.425

8.  Screening of subclinical hepatic encephalopathy.

Authors:  M Groeneweg; W Moerland; J C Quero; W C Hop; P F Krabbe; S W Schalm
Journal:  J Hepatol       Date:  2000-05       Impact factor: 25.083

9.  Cytokines, nitric oxide, and cGMP modulate the permeability of an in vitro model of the human blood-brain barrier.

Authors:  Donald Wong; Katerina Dorovini-Zis; Steven R Vincent
Journal:  Exp Neurol       Date:  2004-12       Impact factor: 5.330

10.  Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.

Authors:  Peter Ferenci; Alan Lockwood; Kevin Mullen; Ralph Tarter; Karin Weissenborn; Andres T Blei
Journal:  Hepatology       Date:  2002-03       Impact factor: 17.425
View more
  5 in total

1.  Moderate grade hyperammonemia induced concordant activation of antioxidant enzymes is associated with prevention of oxidative stress in the brain slices.

Authors:  Aditi Mehrotra; Surendra Kumar Trigun
Journal:  Neurochem Res       Date:  2011-09-16       Impact factor: 3.996

Review 2.  Mechanisms, diagnosis and management of hepatic encephalopathy.

Authors:  Ravi Prakash; Kevin D Mullen
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-08-10       Impact factor: 46.802

3.  Activation of neuronal nitric oxide synthase in cerebellum of chronic hepatic encephalopathy rats is associated with up-regulation of NADPH-producing pathway.

Authors:  Santosh Singh; Surendra K Trigun
Journal:  Cerebellum       Date:  2010-09       Impact factor: 3.847

4.  Effect of glutamine synthesis inhibition with methionine sulfoximine on the nitric oxide-cyclic GMP pathway in the rat striatum treated acutely with ammonia: a microdialysis study.

Authors:  Wojciech Hilgier; Michal Wegrzynowicz; Michal Maczewski; Andrzej Beresewicz; Simo S Oja; Pirjo Saransaari; Jan Albrecht
Journal:  Neurochem Res       Date:  2007-08-29       Impact factor: 3.996

5.  Candesartan, rather than losartan, improves motor dysfunction in thioacetamide-induced chronic liver failure in rats.

Authors:  H A Murad; Z J Gazzaz; S S Ali; M S Ibraheem
Journal:  Braz J Med Biol Res       Date:  2017-09-21       Impact factor: 2.590
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.